Britain's economy grew by a faster-than-expected 0.3% in the second quarter of 2025 after growth of 0.7% in the first three ...

The Trusts’ primary performance objective is to outperform its strategic allocation composite benchmark over the long-term ...

For the quarter, Voya MidCap Opportunities Strategy underperformed the Index on a NAV basis due to both allocation effects ...

Cannabis company Tilray Brands (NASDAQ:TLRY) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling ...

Net cash used in operating activities (GAAP) was $1,400,000 in fiscal Q2 2025, compared to $3,700,000 provided in fiscal Q2 ...

Maiden revenue of $3.4 million in Q2 2025, following the first commercial sale of gold doré bars from the Nalunaq mine. In ...

Revenue-- $564,000 in revenue for fiscal Q2 2025 (period ended June 30, 2025), down from $901,000 in fiscal Q2 2024, reflecting a reduction attributed to lower procedure volumes and a shift in ...

Key Points Jasper Therapeutics (NASDAQ:JSPR) reported a GAAP loss per share of $1.74 for Q2 2025. Research and development expenses (GAAP) nearly doubled to $21.2 million in Q2 2025 from $11.3 million ...

Everus Construction Group, Inc. ( ($ECG) ) has released its Q2 earnings. Here is a breakdown of the information Everus ...

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced better-than-expected revenue in Q2 CY2025, but sales were ...

UK gross domestic product (GDP) is estimated to have increased by 0.3% in Quarter 2 (Apr to June) 2025, following an increase ...

CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) ('CMBT”, 'CMB.TECH” or 'the Company”) will release its second quarter 2025 earnings prior to market opening on Thursday 28 August 2025 and will host a ...